Savior Lifetec Corporation (TPEX:4167)
Taiwan
· Delayed Price · Currency is TWD 19.60
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
Savior Lifetec Revenue
In the year 2024, Savior Lifetec had annual revenue of 1.22B TWD with 15.91% growth. Savior Lifetec had revenue of 276.94M in the quarter ending December 31, 2024, a decrease of -12.91%.
Revenue
1.22B
Revenue Growth
+15.91%
P/S Ratio
5.15
Revenue / Employee
3.17M
Employees
384
Market Cap
6.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 167.05M | 15.91% |
| Dec 31, 2023 | 1.05B | -215.47M | -17.02% |
| Dec 31, 2022 | 1.27B | -478.04M | -27.41% |
| Dec 31, 2021 | 1.74B | -83.46M | -4.57% |
| Dec 31, 2020 | 1.83B | 508.55M | 38.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |